Ana M. González-Angulo
- Oncology top 0.02%
- Cancer Research top 0.02%
- Molecular Biology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Pathology and Forensic Medicine top 0.1%
- Co-authors
- Gabriel N. HortobágyiFunda Meric‐BernstamGordon B. MillsBryan T. HennessyVicente ValeroMassimo CristofanilliW. Fraser SymmansKristine Broglio
- Topics
- Breast Cancer Treatment Studies (132 papers)HER2/EGFR in Cancer Research (84 papers)Cancer Treatment and Pharmacology (53 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Medicine
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Ana M. González-Angulo
276 papers receiving 24.7k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Oncology 15.2k
- Cancer Research 11.4k
- Molecular Biology 8.9k
- Pulmonary and Respiratory Medicine 5.2k
- Pathology and Forensic Medicine 3.8k
Countries citing papers authored by Ana M. González-Angulo
This map shows the geographic impact of Ana M. González-Angulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana M. González-Angulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana M. González-Angulo more than expected).
Fields of papers citing papers by Ana M. González-Angulo
This network shows the impact of papers produced by Ana M. González-Angulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana M. González-Angulo. The network helps show where Ana M. González-Angulo may publish in the future.
Co-authorship network of co-authors of Ana M. González-Angulo
This figure shows the co-authorship network connecting the top 25 collaborators of Ana M. González-Angulo. A scholar is included among the top collaborators of Ana M. González-Angulo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana M. González-Angulo. Ana M. González-Angulo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 10 | |
| 3 | 40 | |
| 4 | 21 | |
| 5 | PD-L1 Expression in Triple-Negative Breast Cancerbreakdown → | 1065 |
| 6 | 258 | |
| 7 | 68 | |
| 8 | 63 | |
| 9 | Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypesbreakdown → | 525 |
| 10 | 93 | |
| 11 | 124 | |
| 12 | 171 | |
| 13 | 85 | |
| 14 | 131 | |
| 15 | 171 | |
| 16 | 241 | |
| 17 | 60 | |
| 18 | 58 | |
| 19 | 19 | |
| 20 | 94 |
About Ana M. González-Angulo
Ana M. González-Angulo is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 281 papers that have together received 25.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (132 papers), HER2/EGFR in Cancer Research (84 papers) and Cancer Treatment and Pharmacology (53 papers). The work is most often cited by research in Cancer Research (11.4k citations), Oncology (15.2k citations) and Pathology and Forensic Medicine (3.8k citations). Ana M. González-Angulo has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Gabriel N. Hortobágyi, Funda Meric‐Bernstam, Gordon B. Mills, Bryan T. Hennessy, Vicente Valero, Massimo Cristofanilli, W. Fraser Symmans, Kristine Broglio, Lajos Pusztai and Fabrice André. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.